GLP-1RA–Associated Diabetic Lumbosacral Radiculoplexus and Common Fibular Neuropathies

AI Imaging Reveals Obesity-Related Nerve Damage; Questions Raised About GLP-1 Drug Effects on Peripheral Nerves

Fascinating nervous system imaging reveals previously unseen obesity-related nerve damage in mice and humans — and some of it may be linked

Study Probes Absolute Risk for ION With GLP-1 Agents

In patients with type 2 diabetes, GLP-1 RAs may be associated with a higher incidence of ischemic optic neuropathy than other medications, c

U.S. Study Suggests GLP-1 RA Drugs Are Associated with Small Increase in Ischemic Optic Neuropathy

A target trial emulation found that people with type 2 diabetes who start glucagon-like peptide-1 receptor agonist (GLP-1RA) therapy had a s

Large Swedish Study Suggests Low Overall Risk of Sudden Vision Loss with GLP-1 RA Use

A nationwide cohort study found a slightly higher risk for nonarteritic anterior ischemic optic neuropathy (NAION) among users of glucagon-l

AI-Powered Imaging Reveals Obesity-Related Nerve Damage, Raises Questions About GLP-1 Drug Effects

Fascinating nervous system imaging reveals previously unseen obesity-related nerve damage in mice and humans — and some of it may be linked

<![CDATA[GLP-1 RAs Linked to Lower Mortality, Amputation Risk in Patients With PAD and Type 2 Diabetes]]>